Methods for rational pegylation of proteins
The present invention relates to the use of simulation technology to rationally optimize the locations and sizes of attached polymeric moieties for modification of therapeutic proteins and the proteins generated from this method.
1. A method of generating a protein with a polymeric moiety attached at a favorable attachment site comprising:
a) inputting a set of coordinates for a target protein into a computer;
b) inputting a set of coordinates for a plurality of polymeric moieties;
c) selecting a criteria for said favorable attachment site based upon at least one desired characteristic,
d) analyzing said structure using a simulation module comprising the steps of:
i) computationally attaching a plurality of conformers of each of said polymeric moieties to a plurality of amino acids in said target protein; and
ii) disallowing conformers at each of said amino acids on the basis of a distance cutoff;
e) generating a matrix of said amino acids and said polymeric moiety that are energetically favorable;
f) selecting based upon said criteria one of said amino acids for attachment of one of said polymeric moieties; and
g) physically making and screening for said at least one desired characteristic said protein with said polymeric moiety attached at said favorable attachment site.
2. A method according to claim 1 wherein said set of polymeric moieties are polymeric conformers.
3. A method according to claim 1 wherein said set of polymeric moieties is generated by chain buildup.
4. A method according to claim 1 wherein said set of polymeric moieties is generated by utilizing a starting polymeric conformer and perturbing said conformer to generate said set.
5. A method according to claim 4 wherein said perturbation is done using a Monte Carlo search.
6. A method according to claim 4 wherein said perturbation is done using a molecular dynamics method.
7. A method according to claim 1 , wherein said protein is a therapeutic protein.
8. A method according to claim 1 , wherein said polymeric moiety is pharmaceutically acceptable.
9. A method according to claim 1 , wherein said polymeric moieties comprises polyethylene glycol (PEG).
10. A method according to claim 1 , wherein said polymeric moiety has a range of about 1000 daltons to about 100,000 daltons.
11. A method according to claim 1 , wherein said polymeric moiety is branched.
12. A method according to claim 1 , wherein said polymeric moiety is unbranched.
13. A method according to claim 1 , wherein said polymeric moiety is labile.
14. A method according to claim 1 , wherein said simulation module includes Monte Carlo, molecular dynamics or combinations thereof.